Methotrexate Injection Recalled Due to Presence of Particulate Matter
Mylan Institutional LLC is recalling Methotrexate Injection vials due to the presence of particulate matter.
- Product
- Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-0146-01; and b) Manufactured for: Mylan Institutional LLC…
- Category
- Drug
- Distribution
- Distributed nationwide